Therapy Areas: Oncology
Genprex receives Canadian Patent Allowance for Reqorsa gene therapy combination in lung cancer
22 June 2026 - Gene therapy company Genprex Inc (NASDAQ: GNPX) disclosed on Monday that it has received a Notice of Allowance from the Canadian Intellectual Property Office for a patent covering the u...
Transgene expands myvac platform into non-small cell lung cancer with TG4070
22 June 2026 - French biotech company Transgene (Euronext Paris:TNG) announced on Monday that it has initiated a randomised Phase 1 trial of TG4070, an individualised neoantigen therapeutic vaccine, i...
Arletta Pharma Solutions names new chief medical officer
22 June 2026 - Arletta Pharma Solutions, a Netherlands-based biopharmaceutical company specialising in innovative therapies for women diagnosed with Female Sexual Disorders (FSD), announced on Friday ...
Oncoinvent reports recruitment milestone in Phase 2 study of Radspherin in ovarian cancer
19 June 2026 - Oncoinvent ASA (Euronext Growth Oslo:ONCIN), a Norway-based clinical-stage radiopharmaceutical company developing innovative treatments for solid cancers, announced on Thursday that its...
FDA accepts Genentech application for Lunsumio and Polivy combination in large B-cell lymphoma
18 June 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), said on Thursday that the US Food and Drug Administration (FDA) has accepted its supplemental...
Getinge launches Fluobeam LS for fluorescence‑guided small‑incision surgery
...